id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT03073070
16:34:treatment,
consumption of biotin supplements or raw eggs within 30 days
1
[ "consumption", "of", "biotin", "supplements", "or", "raw", "eggs", "within", "30", "days" ]
[ 0, 0, 1, 1, 0, 0, 0, 0, 0, 0 ]
NCT01807091
,,,87:99:treatment
Treatment-related mortality (TRM) score < 9.21 corresponding to a TRM rate of 3% when chemotherapy of similar intensity as proposed here is administered to inpatients
1
[ "Treatment-related", "mortality", "(", "TRM", ")", "score", "<", "9.21", "corresponding", "to", "a", "TRM", "rate", "of", "3", "%", "when", "chemotherapy", "of", "similar", "intensity", "as", "proposed", "here", "is", "administered", "to", "inpatients" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02338999
22:37:chronic_disease,48:51:chronic_disease,48:57:chronic_disease,,,137:150:chronic_disease,164:192:treatment,201:212:chronic_disease,366:381:treatment
Patients with active lupus nephritis or active CNS lupus at baseline even if SLEDAI-2K <20. Active disease will be considered as CNS or renal disease that require aggressive immunosuppression. Active CNS disease will be diagnosed based on clinical presentation and physical exam, exclusion of other conditions that could explain symptomatology and, when warranted, ancillary tests (imaging) that support the diagnosis
1
[ "Patients", "with", "active", "lupus", "nephritis", "or", "active", "CNS", "lupus", "at", "baseline", "even", "if", "SLEDAI-2K", "<", "20", ".", "Active", "disease", "will", "be", "considered", "as", "CNS", "or", "renal", "disease", "that", "require", "aggressive", "immunosuppression", ".", "Active", "CNS", "disease", "will", "be", "diagnosed", "based", "on", "clinical", "presentation", "and", "physical", "exam", ",", "exclusion", "of", "other", "conditions", "that", "could", "explain", "symptomatology", "and", ",", "when", "warranted", ",", "ancillary", "tests", "(", "imaging", ")", "that", "support", "the", "diagnosis" ]
[ 0, 0, 0, 2, 2, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT00719888
12:56:chronic_disease
History of human immunodeficiency virus (HIV) infection
1
[ "History", "of", "human", "immunodeficiency", "virus", "(", "HIV", ")", "infection" ]
[ 0, 0, 2, 2, 2, 2, 2, 0, 0 ]
NCT02837510
1:17:treatment,19:29:treatment,31:37:treatment,66:71:treatment,73:83:treatment,84:89:treatment
Anti-depressants (tricyclics, SSRI's, selective and nonselective MAOIs, Wellbutrin/Zyban)
1
[ "Anti-depressants", "(", "tricyclics", ",", "SSRI", "'s", ",", "selective", "and", "nonselective", "MAOIs", ",", "Wellbutrin/Zyban", ")" ]
[ 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1 ]
NCT02946892
1:50:chronic_disease,67:79:treatment,97:122:treatment
Sustained or symptomatic ventricular dysrhythmias uncontrolled by drug therapy or the use of an implantable defibrillator
1
[ "Sustained", "or", "symptomatic", "ventricular", "dysrhythmias", "uncontrolled", "by", "drug", "therapy", "or", "the", "use", "of", "an", "implantable", "defibrillator" ]
[ 2, 2, 2, 2, 2, 0, 0, 1, 1, 0, 0, 0, 0, 0, 1, 1 ]
NCT02064036
1:26:treatment
Previous hormonal therapy
1
[ "Previous", "hormonal", "therapy" ]
[ 1, 1, 1 ]
NCT02204098
1:13:treatment
Chemotherapy
1
[ "Chemotherapy" ]
[ 1 ]
NCT02089607
17:31:treatment
Native aorta or surgical graft
1
[ "Native", "aorta", "or", "surgical", "graft" ]
[ 0, 0, 0, 1, 1 ]
NCT01872975
101:120:treatment,149:175:treatment,211:238:treatment,263:277:cancer
Patient must have had pathologic confirmation of axillary nodal involvement at presentation (before neoadjuvant therapy) based on either a positive fine needle aspirate (FNA) (demonstrating malignant cells) or positive core needle biopsy (demonstrating invasive adenocarcinoma)
1
[ "Patient", "must", "have", "had", "pathologic", "confirmation", "of", "axillary", "nodal", "involvement", "at", "presentation", "(", "before", "neoadjuvant", "therapy", ")", "based", "on", "either", "a", "positive", "fine", "needle", "aspirate", "(", "FNA", ")", "(", "demonstrating", "malignant", "cells", ")", "or", "positive", "core", "needle", "biopsy", "(", "demonstrating", "invasive", "adenocarcinoma", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0 ]
NCT02415387
1:7:chronic_disease
Anemia
1
[ "Anemia" ]
[ 2 ]
NCT02974257
,20:34:chronic_disease
Within 12 hours of cardiac arrest event
1
[ "Within", "12", "hours", "of", "cardiac", "arrest", "event" ]
[ 0, 0, 0, 0, 2, 2, 0 ]
NCT02393794
,,91:100:treatment
their partners must use contraception prior to study entry, continuing for 5 months after treatment
1
[ "their", "partners", "must", "use", "contraception", "prior", "to", "study", "entry", ",", "continuing", "for", "5", "months", "after", "treatment" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT03016351
12:59:chronic_disease
History of cardiovascular disease or cardiovascular events
1
[ "History", "of", "cardiovascular", "disease", "or", "cardiovascular", "events" ]
[ 0, 0, 2, 2, 2, 2, 2 ]
NCT03056339
29:32:chronic_disease
Known positive serology for HIV
1
[ "Known", "positive", "serology", "for", "HIV" ]
[ 0, 0, 0, 0, 2 ]
NCT03175159
1:4:chronic_disease
HIV-uninfected
1
[ "HIV-uninfected" ]
[ 2 ]
NCT02464878
1:35:chronic_disease,,,
Selective or severe IgA deficiency (levels < 5-7 mg/dL)
1
[ "Selective", "or", "severe", "IgA", "deficiency", "(", "levels", "<", "5-7", "mg/dL", ")" ]
[ 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT02901041
32:45:treatment
Must be willing to discontinue psychotherapy for substance use disorder (except A.A.)
1
[ "Must", "be", "willing", "to", "discontinue", "psychotherapy", "for", "substance", "use", "disorder", "(", "except", "A.A", ".", ")" ]
[ 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02329652
1:9:chronic_disease
diabetes or any condition which requires frequent blood pressure monitoring or frequent venipuncture
1
[ "diabetes", "or", "any", "condition", "which", "requires", "frequent", "blood", "pressure", "monitoring", "or", "frequent", "venipuncture" ]
[ 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00909909
24:33:cancer,35:41:cancer,35:40:cancer,,175:193:cancer,230:240:cancer,244:250:treatment
No proven multicentric carcinoma (tumors in different quadrants of the breast or tumor separated by ≥ 4 cm) with other clinically or radiographically suspicious areas in the ipsilateral breast unless confirmed to be negative for malignancy by biopsy
1
[ "No", "proven", "multicentric", "carcinoma", "(", "tumors", "in", "different", "quadrants", "of", "the", "breast", "or", "tumor", "separated", "by", "≥", "4", "cm", ")", "with", "other", "clinically", "or", "radiographically", "suspicious", "areas", "in", "the", "ipsilateral", "breast", "unless", "confirmed", "to", "be", "negative", "for", "malignancy", "by", "biopsy" ]
[ 0, 0, 0, 3, 0, 3, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 3, 0, 1 ]
NCT01952730
1:19:cancer
Hepatic metastases involving both branches of the portal vein or all three hepatic veins
1
[ "Hepatic", "metastases", "involving", "both", "branches", "of", "the", "portal", "vein", "or", "all", "three", "hepatic", "veins" ]
[ 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02964741
15:35:treatment,,
No overuse of analgesic medication, defined as regular intake on ≥15 days per month for more than 3 months
1
[ "No", "overuse", "of", "analgesic", "medication", ",", "defined", "as", "regular", "intake", "on", "≥15", "days", "per", "month", "for", "more", "than", "3", "months" ]
[ 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03179163
12:27:allergy_name
allergy to test substances
1
[ "allergy", "to", "test", "substances" ]
[ 0, 0, 4, 4 ]
NCT01384513
1:29:treatment,,,,,
ematopoietic Cell Transplant-Comorbidity Index (HCT-CI) Score > 4 points for patients ≥ 60 years old or > 5 points for patients < 60
1
[ "ematopoietic", "Cell", "Transplant-Comorbidity", "Index", "(", "HCT-CI", ")", "Score", ">", "4", "points", "for", "patients", "≥", "60", "years", "old", "or", ">", "5", "points", "for", "patients", "<", "60" ]
[ 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02639546
116:143:treatment,145:164:treatment,166:179:treatment
Measurable disease as defined by mINRC, RANO criteria for HGG, RANO criteria for LGG, RECIST v1.1, or evaluable by nuclear medicine techniques, immunocytochemistry, tumor markers, or other reliable measures
1
[ "Measurable", "disease", "as", "defined", "by", "mINRC", ",", "RANO", "criteria", "for", "HGG", ",", "RANO", "criteria", "for", "LGG", ",", "RECIST", "v1.1", ",", "or", "evaluable", "by", "nuclear", "medicine", "techniques", ",", "immunocytochemistry", ",", "tumor", "markers", ",", "or", "other", "reliable", "measures" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 1, 0, 1, 1, 0, 0, 0, 0, 0 ]
NCT03123783
15:39:cancer,67:81:treatment,89:110:treatment,120:143:treatment
Subjects with BRAF activating mutation could have also received a BRAF inhibitor and/or MEK inhibitor regimen prior to anti-PD-1/PD-L1 therapy
1
[ "Subjects", "with", "BRAF", "activating", "mutation", "could", "have", "also", "received", "a", "BRAF", "inhibitor", "and/or", "MEK", "inhibitor", "regimen", "prior", "to", "anti-PD-1/PD-L1", "therapy" ]
[ 0, 0, 1, 1, 3, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 1, 1 ]
NCT02394535
34:64:cancer
Cytologic or histologic proof of adenocarcinoma of the pancreas
1
[ "Cytologic", "or", "histologic", "proof", "of", "adenocarcinoma", "of", "the", "pancreas" ]
[ 0, 0, 0, 0, 0, 3, 3, 3, 3 ]
NCT03153982
1:16:chronic_disease
Acute hepatitis
1
[ "Acute", "hepatitis" ]
[ 2, 2 ]
NCT02508311
18:33:treatment
Currently taking corticosteroids
1
[ "Currently", "taking", "corticosteroids" ]
[ 0, 0, 1 ]
NCT01902810
23:67:chronic_disease,69:75:chronic_disease,85:113:chronic_disease
Currently treated for Chronic Obstructive Pulmonary Disease (COPD), asthma or other chronic pulmonary conditions
1
[ "Currently", "treated", "for", "Chronic", "Obstructive", "Pulmonary", "Disease", "(", "COPD", ")", ",", "asthma", "or", "other", "chronic", "pulmonary", "conditions" ]
[ 0, 0, 0, 2, 2, 2, 2, 2, 0, 0, 0, 2, 0, 0, 2, 2, 2 ]
NCT02453113
12:15:chronic_disease
History of HIV
1
[ "History", "of", "HIV" ]
[ 0, 0, 2 ]
NCT02567422
,,,,,299:335:treatment,337:369:treatment,374:382:treatment
Patients must have measurable disease, defined as at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded for non-nodal lesions and short axis for nodal lesions) as >= 20 mm (>= 2 cm) with conventional techniques or as >= 10 mm (>= 1 cm) with spiral computed tomography (CT) scan, magnetic resonance imaging (MRI), or calipers by clinical exam
1
[ "Patients", "must", "have", "measurable", "disease", ",", "defined", "as", "at", "least", "one", "lesion", "that", "can", "be", "accurately", "measured", "in", "at", "least", "one", "dimension", "(", "longest", "diameter", "to", "be", "recorded", "for", "non-nodal", "lesions", "and", "short", "axis", "for", "nodal", "lesions", ")", "as", ">", "=", "20", "mm", "(", ">", "=", "2", "cm", ")", "with", "conventional", "techniques", "or", "as", ">", "=", "10", "mm", "(", ">", "=", "1", "cm", ")", "with", "spiral", "computed", "tomography", "(", "CT", ")", "scan", ",", "magnetic", "resonance", "imaging", "(", "MRI", ")", ",", "or", "calipers", "by", "clinical", "exam" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 1, 0, 0, 0 ]
NCT02418195
1:13:treatment
Chemotherapy
1
[ "Chemotherapy" ]
[ 1 ]
NCT02555280
8:25:chronic_disease
Severe facet hypertrophy that requires extensive bone removal which would cause instability
1
[ "Severe", "facet", "hypertrophy", "that", "requires", "extensive", "bone", "removal", "which", "would", "cause", "instability" ]
[ 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01526603
,,,,67:91:chronic_disease
shortening fraction ≥ 27% or ejection fraction ≥ 50%, no clinical congestive heart failure
1
[ "shortening", "fraction", "≥", "27", "%", "or", "ejection", "fraction", "≥", "50", "%", ",", "no", "clinical", "congestive", "heart", "failure" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2 ]
NCT02207465
1:52:treatment,
Treatment with an investigational anti-cancer agent within 4 weeks prior to enrollment into the study
1
[ "Treatment", "with", "an", "investigational", "anti-cancer", "agent", "within", "4", "weeks", "prior", "to", "enrollment", "into", "the", "study" ]
[ 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02305537
26:64:chronic_disease
those who exhibit severe behavioral disinhibition or aggression
1
[ "those", "who", "exhibit", "severe", "behavioral", "disinhibition", "or", "aggression" ]
[ 0, 0, 0, 0, 2, 2, 2, 2 ]
NCT02565498
12:22:cancer,64:84:cancer,100:117:cancer
concurrent malignancy with the exception of adequately treated basal cell carcinoma of the skin or carcinoma in-situ of the cervix
1
[ "concurrent", "malignancy", "with", "the", "exception", "of", "adequately", "treated", "basal", "cell", "carcinoma", "of", "the", "skin", "or", "carcinoma", "in-situ", "of", "the", "cervix" ]
[ 0, 3, 0, 0, 0, 0, 0, 0, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02125786
23:44:cancer,,
Any patient with both metastatic ependymoma and age < 3 years at the time of enrollment
1
[ "Any", "patient", "with", "both", "metastatic", "ependymoma", "and", "age", "<", "3", "years", "at", "the", "time", "of", "enrollment" ]
[ 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02151175
34:86:treatment,90:99:treatment,104:114:treatment,115:134:chronic_disease
Subjects who have been offered a non-dominant anterior-mesial temporal lobe resection as treatment for medication refractory epilepsy
1
[ "Subjects", "who", "have", "been", "offered", "a", "non-dominant", "anterior-mesial", "temporal", "lobe", "resection", "as", "treatment", "for", "medication", "refractory", "epilepsy" ]
[ 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 1, 0, 1, 2, 2 ]
NCT03152058
12:24:chronic_disease
History of tuberculosis or untreated positive PPD
1
[ "History", "of", "tuberculosis", "or", "untreated", "positive", "PPD" ]
[ 0, 0, 2, 0, 0, 0, 0 ]
NCT02770326
1:4:chronic_disease,,
HIV infection with CD4 count <240
1
[ "HIV", "infection", "with", "CD4", "count", "<", "240" ]
[ 2, 0, 0, 0, 0, 0, 0 ]
NCT02819843
,,76:102:treatment
History of high grade (CTCAE ≥ Grade 3) immune mediated adverse event from prior cancer immunotherapy
1
[ "History", "of", "high", "grade", "(", "CTCAE", "≥", "Grade", "3", ")", "immune", "mediated", "adverse", "event", "from", "prior", "cancer", "immunotherapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT00719888
11:35:treatment,
Any prior myeloablative transplant within the last 6 months
1
[ "Any", "prior", "myeloablative", "transplant", "within", "the", "last", "6", "months" ]
[ 0, 0, 1, 1, 0, 0, 0, 0, 0 ]
NCT03161028
9:34:chronic_disease,46:48:chronic_disease,56:62:cancer,64:77:chronic_disease,89:112:chronic_disease,114:144:chronic_disease
Current major disease or disorder other than MS (e.g., cancer, renal disease, end-stage cardiopulmonary disease, post-traumatic stress disorder, etc.) that may interfere with study procedures
1
[ "Current", "major", "disease", "or", "disorder", "other", "than", "MS", "(", "e.g.", ",", "cancer", ",", "renal", "disease", ",", "end-stage", "cardiopulmonary", "disease", ",", "post-traumatic", "stress", "disorder", ",", "etc", ".", ")", "that", "may", "interfere", "with", "study", "procedures" ]
[ 0, 2, 2, 2, 2, 0, 0, 2, 0, 0, 0, 3, 0, 2, 2, 0, 0, 2, 2, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03181516
12:22:allergy_name
Allergy to strawberry
1
[ "Allergy", "to", "strawberry" ]
[ 0, 0, 4 ]
NCT02210650
9:16:treatment,
Current CT scan within the 90-day pre-operative period
1
[ "Current", "CT", "scan", "within", "the", "90-day", "pre-operative", "period" ]
[ 0, 1, 1, 0, 0, 0, 0, 0 ]
NCT02479698
21:44:chronic_disease
Patients with other uncontrolled infections
1
[ "Patients", "with", "other", "uncontrolled", "infections" ]
[ 0, 0, 0, 2, 2 ]
NCT02765633
38:62:chronic_disease,,,,,,,,
Participants with evidence of severe hepatic or renal failure [aspartate aminotransferase (AST) or alanine aminotransferase (ALT) greater than three times normal for age or total bilirubin greater than 20 milligrams (mg)/deciliter (dL); creatinine greater than 2 times the normal upper limit]
1
[ "Participants", "with", "evidence", "of", "severe", "hepatic", "or", "renal", "failure", "[", "aspartate", "aminotransferase", "(", "AST", ")", "or", "alanine", "aminotransferase", "(", "ALT", ")", "greater", "than", "three", "times", "normal", "for", "age", "or", "total", "bilirubin", "greater", "than", "20", "milligrams", "(", "mg", ")", "/deciliter", "(", "dL", ")", ";", "creatinine", "greater", "than", "2", "times", "the", "normal", "upper", "limit", "]" ]
[ 0, 0, 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02233322
1:25:chronic_disease,32:46:chronic_disease,48:57:chronic_disease
severe end-organ disease, e.g. cardiovascular, pulmonary, etc, which may limit ability to complete study
1
[ "severe", "end-organ", "disease", ",", "e.g", ".", "cardiovascular", ",", "pulmonary", ",", "etc", ",", "which", "may", "limit", "ability", "to", "complete", "study" ]
[ 2, 2, 2, 0, 0, 0, 2, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02496208
97:109:treatment,,322:355:treatment,373:391:treatment,427:438:treatment,,,,,,,,946:963:treatment,
The effects of the drugs used in this trial on the developing human fetus are unknown; however, cabozantinib was embryolethal in rats at exposures below the 140mg dose in the label, with increased incidences of skeletal variations in rats and visceral variations and malformations in rabbits; for this reason and because tyrosine kinase inhibitors agents as well as other therapeutic agents used in this trial are known to be teratogenic, women of child-bearing potential and men must agree to use adequate contraception, as defined below, prior to study entry and for the duration of study participation; should a woman become pregnant or suspect she is pregnant while she is participating in this study, she should inform her treating physician immediately; men treated or enrolled on this protocol must also agree to use adequate contraception prior to the study, for the duration of study participation, and 7 months after completion of all study medications; women treated or enrolled on this protocol must also agree to use adequate contraception prior to the study, for the duration of study participation, and for 5 months after completion of all study medications
1
[ "The", "effects", "of", "the", "drugs", "used", "in", "this", "trial", "on", "the", "developing", "human", "fetus", "are", "unknown", ";", "however", ",", "cabozantinib", "was", "embryolethal", "in", "rats", "at", "exposures", "below", "the", "140mg", "dose", "in", "the", "label", ",", "with", "increased", "incidences", "of", "skeletal", "variations", "in", "rats", "and", "visceral", "variations", "and", "malformations", "in", "rabbits", ";", "for", "this", "reason", "and", "because", "tyrosine", "kinase", "inhibitors", "agents", "as", "well", "as", "other", "therapeutic", "agents", "used", "in", "this", "trial", "are", "known", "to", "be", "teratogenic", ",", "women", "of", "child-bearing", "potential", "and", "men", "must", "agree", "to", "use", "adequate", "contraception", ",", "as", "defined", "below", ",", "prior", "to", "study", "entry", "and", "for", "the", "duration", "of", "study", "participation", ";", "should", "a", "woman", "become", "pregnant", "or", "suspect", "she", "is", "pregnant", "while", "she", "is", "participating", "in", "this", "study", ",", "she", "should", "inform", "her", "treating", "physician", "immediately", ";", "men", "treated", "or", "enrolled", "on", "this", "protocol", "must", "also", "agree", "to", "use", "adequate", "contraception", "prior", "to", "the", "study", ",", "for", "the", "duration", "of", "study", "participation", ",", "and", "7", "months", "after", "completion", "of", "all", "study", "medications", ";", "women", "treated", "or", "enrolled", "on", "this", "protocol", "must", "also", "agree", "to", "use", "adequate", "contraception", "prior", "to", "the", "study", ",", "for", "the", "duration", "of", "study", "participation", ",", "and", "for", "5", "months", "after", "completion", "of", "all", "study", "medications" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01433965
1:37:chronic_disease
Impaired gastrointestinal absorption
1
[ "Impaired", "gastrointestinal", "absorption" ]
[ 2, 2, 2 ]
NCT02581215
29:38:treatment
Known allergy to any of the treatment components
1
[ "Known", "allergy", "to", "any", "of", "the", "treatment", "components" ]
[ 0, 0, 0, 0, 0, 0, 1, 0 ]
NCT00737893
30:56:chronic_disease
The patient has a history of high or low blood pressure that is not controlled
1
[ "The", "patient", "has", "a", "history", "of", "high", "or", "low", "blood", "pressure", "that", "is", "not", "controlled" ]
[ 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 2, 0, 0, 0, 0 ]
NCT02419495
18:54:treatment
must have failed prior standard curative chemotherapy for their disease
1
[ "must", "have", "failed", "prior", "standard", "curative", "chemotherapy", "for", "their", "disease" ]
[ 0, 0, 0, 1, 1, 1, 1, 0, 0, 0 ]
NCT00630565
29:57:treatment,82:105:treatment,129:147:treatment
Patients who cannot receive total body irradiation (TBI) (for example those with prior radiation therapy) will also receive the Bu/CY conditioning
1
[ "Patients", "who", "can", "not", "receive", "total", "body", "irradiation", "(", "TBI", ")", "(", "for", "example", "those", "with", "prior", "radiation", "therapy", ")", "will", "also", "receive", "the", "Bu/CY", "conditioning" ]
[ 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 1, 1 ]
NCT03006770
12:22:cancer,
history of malignancy within 5 years prior to study entry
1
[ "history", "of", "malignancy", "within", "5", "years", "prior", "to", "study", "entry" ]
[ 0, 0, 3, 0, 0, 0, 0, 0, 0, 0 ]
NCT03037983
8:19:chronic_disease,21:37:chronic_disease,47:84:chronic_disease,100:122:chronic_disease
Have a mass lesion, cerebral infarct or other active central nervous system disease, or history of traumatic brain injury
1
[ "Have", "a", "mass", "lesion", ",", "cerebral", "infarct", "or", "other", "active", "central", "nervous", "system", "disease", ",", "or", "history", "of", "traumatic", "brain", "injury" ]
[ 0, 0, 2, 2, 0, 2, 2, 0, 0, 2, 2, 2, 2, 2, 0, 0, 0, 0, 2, 2, 2 ]
NCT02481765
66:78:treatment
Intensive medical treatment means that the subject is undergoing chemotherapy for a hematologic/oncologic condition, is carrying a pacemaker or has been diagnosed with a cardiac anomaly which causes cardiac insufficiency not compensated with medications
1
[ "Intensive", "medical", "treatment", "means", "that", "the", "subject", "is", "undergoing", "chemotherapy", "for", "a", "hematologic/oncologic", "condition", ",", "is", "carrying", "a", "pacemaker", "or", "has", "been", "diagnosed", "with", "a", "cardiac", "anomaly", "which", "causes", "cardiac", "insufficiency", "not", "compensated", "with", "medications" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02346929
1:9:chronic_disease
dementia
1
[ "dementia" ]
[ 2 ]
NCT03109431
1:4:chronic_disease
HIV-positive serostatus
1
[ "HIV-positive", "serostatus" ]
[ 2, 0 ]
NCT02541565
,,,80:88:cancer
emoglobin >= 9 g/dL or >= 5.6 mmol/L except in cases of marrow infiltration by lymphoma
1
[ "emoglobin", ">", "=", "9", "g/dL", "or", ">", "=", "5.6", "mmol/L", "except", "in", "cases", "of", "marrow", "infiltration", "by", "lymphoma" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3 ]
NCT03135522
14:25:cancer
negative for lung cancer
1
[ "negative", "for", "lung", "cancer" ]
[ 0, 0, 3, 3 ]
NCT02487095
43:70:chronic_disease
Subjects with both platinum-sensitive and platinum-refractory disease
1
[ "Subjects", "with", "both", "platinum-sensitive", "and", "platinum-refractory", "disease" ]
[ 0, 0, 0, 0, 0, 2, 2 ]
NCT02404194
,13:22:chronic_disease
One or more psychosis-risk syndromes as defined by the Structured Interview for Psychosis-Risk Syndromes (SIPS)
1
[ "One", "or", "more", "psychosis-risk", "syndromes", "as", "defined", "by", "the", "Structured", "Interview", "for", "Psychosis-Risk", "Syndromes", "(", "SIPS", ")" ]
[ 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02542657
,121:128:cancer,
For patients without a measurable serum or urine M-component or serum free light chain level: % marrow involvement with myeloma (absolute increase must be >= 10%)
1
[ "For", "patients", "without", "a", "measurable", "serum", "or", "urine", "M-component", "or", "serum", "free", "light", "chain", "level", ":", "%", "marrow", "involvement", "with", "myeloma", "(", "absolute", "increase", "must", "be", ">", "=", "10", "%", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01333046
20:44:treatment
Patients receiving systemic corticosteroids
1
[ "Patients", "receiving", "systemic", "corticosteroids" ]
[ 0, 0, 1, 1 ]
NCT03131037
1:33:chronic_disease
end-stage liver or renal disease
1
[ "end-stage", "liver", "or", "renal", "disease" ]
[ 2, 2, 2, 2, 2 ]
NCT02762006
1:31:chronic_disease
controlled atrial fibrillation
1
[ "controlled", "atrial", "fibrillation" ]
[ 2, 2, 2 ]
NCT02753283
62:71:treatment
Those with a history of hypocalcemia or contraindication for treatment
1
[ "Those", "with", "a", "history", "of", "hypocalcemia", "or", "contraindication", "for", "treatment" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT03113760
25:76:chronic_disease
Patients suffering from familial hemophagocytic lymphohistiocytosis (f HLH)
1
[ "Patients", "suffering", "from", "familial", "hemophagocytic", "lymphohistiocytosis", "(", "f", "HLH", ")" ]
[ 0, 0, 0, 2, 2, 2, 2, 2, 0, 0 ]
NCT02277613
10:32:treatment
Previous solid organ transplant
1
[ "Previous", "solid", "organ", "transplant" ]
[ 0, 1, 1, 1 ]
NCT02016924
,,111:120:treatment
females of childbearing potential must agree to utilize highly effective contraception methods while on study treatment or agree to abstain from heterosexual intercourse throughout the study period
1
[ "females", "of", "childbearing", "potential", "must", "agree", "to", "utilize", "highly", "effective", "contraception", "methods", "while", "on", "study", "treatment", "or", "agree", "to", "abstain", "from", "heterosexual", "intercourse", "throughout", "the", "study", "period" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02669173
1:55:chronic_disease
Active infection with hepatitis B or hepatitis C virus
1
[ "Active", "infection", "with", "hepatitis", "B", "or", "hepatitis", "C", "virus" ]
[ 2, 2, 2, 2, 2, 2, 2, 2, 2 ]
NCT03082612
46:58:treatment
Treatment plans to include weekly outpatient chemotherapy
1
[ "Treatment", "plans", "to", "include", "weekly", "outpatient", "chemotherapy" ]
[ 0, 0, 0, 0, 0, 0, 1 ]
NCT01306045
38:62:chronic_disease
Ongoing or uncontrolled, symptomatic congestive heart failure (Class III or IV as defined by the NYHA functional classification system
1
[ "Ongoing", "or", "uncontrolled", ",", "symptomatic", "congestive", "heart", "failure", "(", "Class", "III", "or", "IV", "as", "defined", "by", "the", "NYHA", "functional", "classification", "system" ]
[ 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02124772
,,83:104:treatment,
platelets >=75,000/ microliter (transfusion independent, defined as not receiving platelet transfusions within a 7 day period prior to enrollment)
1
[ "platelets", ">", "=75,000/", "microliter", "(", "transfusion", "independent", ",", "defined", "as", "not", "receiving", "platelet", "transfusions", "within", "a", "7", "day", "period", "prior", "to", "enrollment", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02567422
33:36:chronic_disease
patients with poorly controlled HIV
1
[ "patients", "with", "poorly", "controlled", "HIV" ]
[ 0, 0, 0, 0, 2 ]
NCT03088709
,78:90:treatment
Less than twenty-one days have elapsed since the subject's last radiation or chemotherapy prior to conditioning
1
[ "Less", "than", "twenty-one", "days", "have", "elapsed", "since", "the", "subject", "'s", "last", "radiation", "or", "chemotherapy", "prior", "to", "conditioning" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0 ]
NCT02468453
26:71:chronic_disease,83:96:chronic_disease,100:104:chronic_disease,125:154:treatment
Subject has a history of immunosuppression/immune deficiency disorders (including HIV infection or AIDS) or currently using immunosuppressive medications
1
[ "Subject", "has", "a", "history", "of", "immunosuppression/immune", "deficiency", "disorders", "(", "including", "HIV", "infection", "or", "AIDS", ")", "or", "currently", "using", "immunosuppressive", "medications" ]
[ 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 2, 2, 0, 2, 0, 0, 0, 0, 1, 1 ]
NCT02548104
1:19:chronic_disease
Systemic infection
1
[ "Systemic", "infection" ]
[ 2, 2 ]
NCT02739035
1:18:chronic_disease
Renal dysfunction
1
[ "Renal", "dysfunction" ]
[ 2, 2 ]
NCT02481713
14:32:chronic_disease
diagnosis of psychotic disorder
1
[ "diagnosis", "of", "psychotic", "disorder" ]
[ 0, 0, 2, 2 ]
NCT02542202
32:55:treatment
Patients may not have received prior radiation therapy to a site of recurrence which would require overlap of appreciable radiation dose
1
[ "Patients", "may", "not", "have", "received", "prior", "radiation", "therapy", "to", "a", "site", "of", "recurrence", "which", "would", "require", "overlap", "of", "appreciable", "radiation", "dose" ]
[ 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02632422
1:10:chronic_disease,17:24:chronic_disease,27:39:chronic_disease,41:63:chronic_disease,65:82:chronic_disease,84:103:chronic_disease,135:159:chronic_disease,200:216:chronic_disease
infection (e.g. bladder), hypertension, cardiovascular disease, pulmonary disease, severe osteoporosis (history of fractures), active heterotopic ossification in the lower extremities, or history of peripheral nerve injury in the legs
1
[ "infection", "(", "e.g", ".", "bladder", ")", ",", "hypertension", ",", "cardiovascular", "disease", ",", "pulmonary", "disease", ",", "severe", "osteoporosis", "(", "history", "of", "fractures", ")", ",", "active", "heterotopic", "ossification", "in", "the", "lower", "extremities", ",", "or", "history", "of", "peripheral", "nerve", "injury", "in", "the", "legs" ]
[ 2, 0, 0, 0, 2, 0, 0, 2, 0, 2, 2, 0, 2, 2, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0 ]
NCT02565199
12:22:chronic_disease,,
No current depression (score less than 7 on the Hamilton Depression Rating Scale (HDRS))
1
[ "No", "current", "depression", "(", "score", "less", "than", "7", "on", "the", "Hamilton", "Depression", "Rating", "Scale", "(", "HDRS", ")", ")" ]
[ 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02496208
,68:77:treatment
To any other site(s) within 28 days before the first dose of study treatment
1
[ "To", "any", "other", "site", "(", "s", ")", "within", "28", "days", "before", "the", "first", "dose", "of", "study", "treatment" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT01999179
55:70:treatment
Participation in another clinical trial that requires anticoagulation
1
[ "Participation", "in", "another", "clinical", "trial", "that", "requires", "anticoagulation" ]
[ 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02494869
1:20:chronic_disease
Respiratory failure
1
[ "Respiratory", "failure" ]
[ 2, 2 ]
NCT03120728
28:41:cancer
current or past history of breast cancer
1
[ "current", "or", "past", "history", "of", "breast", "cancer" ]
[ 0, 0, 0, 0, 0, 3, 3 ]
NCT01420887
28:31:treatment,35:65:treatment,75:93:chronic_disease,102:116:treatment
Contraindication to use of CPM or regional brachial plexus block, such as bleeding diathesis, use of anticoagulants or severe restriction in shoulder range of movement
1
[ "Contraindication", "to", "use", "of", "CPM", "or", "regional", "brachial", "plexus", "block", ",", "such", "as", "bleeding", "diathesis", ",", "use", "of", "anticoagulants", "or", "severe", "restriction", "in", "shoulder", "range", "of", "movement" ]
[ 0, 0, 0, 0, 1, 0, 1, 1, 1, 1, 0, 0, 0, 2, 2, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01730118
10:36:treatment,39:62:treatment,68:89:treatment,92:130:treatment,141:164:treatment
Naive to trastuzumab (Herceptin(TM)), pertuzumab (Perjeta(TM)) and lapatinib (Tykerb(TM)), ado-trastuzumab emtansine (Kadcyla(TM)) or other HER2-directed therapies
1
[ "Naive", "to", "trastuzumab", "(", "Herceptin", "(", "TM", ")", ")", ",", "pertuzumab", "(", "Perjeta", "(", "TM", ")", ")", "and", "lapatinib", "(", "Tykerb", "(", "TM", ")", ")", ",", "ado-trastuzumab", "emtansine", "(", "Kadcyla", "(", "TM", ")", ")", "or", "other", "HER2-directed", "therapies" ]
[ 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT03060096
16:25:chronic_disease,
Self -reported psychotic symptoms in the last 30 days
1
[ "Self", "-reported", "psychotic", "symptoms", "in", "the", "last", "30", "days" ]
[ 0, 0, 2, 0, 0, 0, 0, 0, 0 ]
NCT02466971
29:80:chronic_disease
Patient does not have known glucose‐6‐phosphate dehydrogenase (G6PD) deficiency (G6PD testing optional)
1
[ "Patient", "does", "not", "have", "known", "glucose‐6‐phosphate", "dehydrogenase", "(", "G6PD", ")", "deficiency", "(", "G6PD", "testing", "optional", ")" ]
[ 0, 0, 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT02265874
57:68:chronic_disease,
Eligible adult patients will have histologically proven sarcoidosis, diagnosed at least 6 months before screening
1
[ "Eligible", "adult", "patients", "will", "have", "histologically", "proven", "sarcoidosis", ",", "diagnosed", "at", "least", "6", "months", "before", "screening" ]
[ 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01570816
29:38:chronic_disease,
problems walking because of paralysis for more than 6 months
1
[ "problems", "walking", "because", "of", "paralysis", "for", "more", "than", "6", "months" ]
[ 0, 0, 0, 0, 2, 0, 0, 0, 0, 0 ]
NCT02257424
24:43:chronic_disease
Subjects with moderate valvular thickening
1
[ "Subjects", "with", "moderate", "valvular", "thickening" ]
[ 0, 0, 0, 2, 2 ]
NCT00980538
50:62:chronic_disease,64:83:chronic_disease,238:247:treatment,253:256:treatment
Any active clinically significant disease (e.g., pancreatitis, cardiac dysfunction) or findings of medical history, laboratory or physical examination that, in the investigator's opinion, would compromise the participant's safety during treatment with ETR
1
[ "Any", "active", "clinically", "significant", "disease", "(", "e.g.", ",", "pancreatitis", ",", "cardiac", "dysfunction", ")", "or", "findings", "of", "medical", "history", ",", "laboratory", "or", "physical", "examination", "that", ",", "in", "the", "investigator", "'s", "opinion", ",", "would", "compromise", "the", "participant", "'s", "safety", "during", "treatment", "with", "ETR" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1 ]
NCT01942018
1:32:chronic_disease
Acute gastrointestinal bleeding
1
[ "Acute", "gastrointestinal", "bleeding" ]
[ 2, 2, 2 ]
NCT03056339
13:44:chronic_disease
Presence of active neurological disorder(s)
1
[ "Presence", "of", "active", "neurological", "disorder", "(", "s", ")" ]
[ 0, 0, 2, 2, 2, 0, 0, 0 ]